148 related articles for article (PubMed ID: 12150874)
1. Total synthesis and evaluation of lamellarin alpha 20-Sulfate analogues.
Ridley CP; Reddy MV; Rocha G; Bushman FD; Faulkner DJ
Bioorg Med Chem; 2002 Oct; 10(10):3285-90. PubMed ID: 12150874
[TBL] [Abstract][Full Text] [Related]
2. Lamellarin alpha 20-sulfate, an inhibitor of HIV-1 integrase active against HIV-1 virus in cell culture.
Reddy MV; Rao MR; Rhodes D; Hansen MS; Rubins K; Bushman FD; Venkateswarlu Y; Faulkner DJ
J Med Chem; 1999 Jun; 42(11):1901-7. PubMed ID: 10354398
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and structure-activity relationship study of potent cytotoxic analogues of the marine alkaloid Lamellarin D.
Pla D; Marchal A; Olsen CA; Francesch A; Cuevas C; Albericio F; Alvarez M
J Med Chem; 2006 Jun; 49(11):3257-68. PubMed ID: 16722644
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, structure-activity relationships, and mechanism of action of anti-HIV-1 lamellarin α 20-sulfate analogues.
Kamiyama H; Kubo Y; Sato H; Yamamoto N; Fukuda T; Ishibashi F; Iwao M
Bioorg Med Chem; 2011 Dec; 19(24):7541-50. PubMed ID: 22071527
[TBL] [Abstract][Full Text] [Related]
5. Design, Synthesis and Structure-Activity Relationship Studies of Glycosylated Derivatives of Marine Natural Product Lamellarin D.
Zheng L; Gao T; Ge Z; Ma Z; Xu J; Ding W; Shen L
Eur J Med Chem; 2021 Mar; 214():113226. PubMed ID: 33582387
[TBL] [Abstract][Full Text] [Related]
6. Topoisomerase I-mediated DNA cleavage as a guide to the development of antitumor agents derived from the marine alkaloid lamellarin D: triester derivatives incorporating amino acid residues.
Tardy C; Facompré M; Laine W; Baldeyrou B; García-Gravalos D; Francesch A; Mateo C; Pastor A; Jiménez JA; Manzanares I; Cuevas C; Bailly C
Bioorg Med Chem; 2004 Apr; 12(7):1697-712. PubMed ID: 15028262
[TBL] [Abstract][Full Text] [Related]
7. Recent advances in lamellarin alkaloids: isolation, synthesis and activity.
Pla D; Albericio F; Alvarez M
Anticancer Agents Med Chem; 2008 Oct; 8(7):746-60. PubMed ID: 18855577
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological evaluation of a D-ring-contracted analogue of lamellarin D.
Colligs V; Hansen SP; Imbri D; Seo EJ; Kadioglu O; Efferth T; Opatz T
Bioorg Med Chem; 2017 Nov; 25(22):6137-6148. PubMed ID: 28233677
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis, and biological evaluation of novel benzo[6,7]indolo[3,4-c]isoquinolines as anticancer agents with topoisomerase I inhibition.
Sakai K; Soshima T; Hirose Y; Ishibashi F; Hirao S
Bioorg Med Chem Lett; 2024 May; 104():129710. PubMed ID: 38518997
[TBL] [Abstract][Full Text] [Related]
10. Design and total synthesis of Mannich derivatives of marine natural product lamellarin D as cytotoxic agents.
Shen L; Xie N; Yang B; Hu Y; Zhang Y
Eur J Med Chem; 2014 Oct; 85():807-17. PubMed ID: 25189362
[TBL] [Abstract][Full Text] [Related]
11. Cancer cell mitochondria are direct proapoptotic targets for the marine antitumor drug lamellarin D.
Kluza J; Gallego MA; Loyens A; Beauvillain JC; Sousa-Faro JM; Cuevas C; Marchetti P; Bailly C
Cancer Res; 2006 Mar; 66(6):3177-87. PubMed ID: 16540669
[TBL] [Abstract][Full Text] [Related]
12. Design and synthesis of lamellarin D analogues targeting topoisomerase I.
Ohta T; Fukuda T; Ishibashi F; Iwao M
J Org Chem; 2009 Nov; 74(21):8143-53. PubMed ID: 19791738
[TBL] [Abstract][Full Text] [Related]
13. Pyrrolo[2,1-alpha]isoquinoline as a skeleton for the synthesis of bioactive lamellarin H.
You YC; Wang AL; Li DP; Yang G
Biomed Mater; 2006 Sep; 1(3):L7-9. PubMed ID: 18458386
[TBL] [Abstract][Full Text] [Related]
14. Lamellarin D bioconjugates I: Synthesis and cellular internalization of PEG-derivatives.
Pla D; Francesch A; Calvo P; Cuevas C; Aligué R; Albericio F; Alvarez M
Bioconjug Chem; 2009 Jun; 20(6):1100-11. PubMed ID: 19472995
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and topoisomerase I inhibitory activity of a novel diazaindeno[2,1-b]phenanthrene analogue of Lamellarin D.
Cananzi S; Merlini L; Artali R; Beretta GL; Zaffaroni N; Dallavalle S
Bioorg Med Chem; 2011 Aug; 19(16):4971-84. PubMed ID: 21783369
[TBL] [Abstract][Full Text] [Related]
16. Cytotoxicities and structure-activity relationships of natural and unnatural lamellarins toward cancer cell lines.
Chittchang M; Batsomboon P; Ruchirawat S; Ploypradith P
ChemMedChem; 2009 Mar; 4(3):457-65. PubMed ID: 19152364
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of chromeno[3,4-b]indoles as Lamellarin D analogues: a novel DYRK1A inhibitor class.
Neagoie C; Vedrenne E; Buron F; Mérour JY; Rosca S; Bourg S; Lozach O; Meijer L; Baldeyrou B; Lansiaux A; Routier S
Eur J Med Chem; 2012 Mar; 49():379-96. PubMed ID: 22305342
[TBL] [Abstract][Full Text] [Related]
18. Lamellarins, from A to Z: a family of anticancer marine pyrrole alkaloids.
Bailly C
Curr Med Chem Anticancer Agents; 2004 Jul; 4(4):363-78. PubMed ID: 15281908
[TBL] [Abstract][Full Text] [Related]
19. Modular total synthesis of lamellarin D.
Pla D; Marchal A; Olsen CA; Albericio F; Alvarez M
J Org Chem; 2005 Sep; 70(20):8231-4. PubMed ID: 16277357
[TBL] [Abstract][Full Text] [Related]
20. Lamellarin D bioconjugates II: Synthesis and cellular internalization of dendrimer and nuclear location signal derivatives.
Pla D; Martí M; Farrera-Sinfreu J; Pulido D; Francesch A; Calvo P; Cuevas C; Royo M; Aligué R; Albericio F; Alvarez M
Bioconjug Chem; 2009 Jun; 20(6):1112-21. PubMed ID: 19472996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
